Patient Guide: Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 20 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07078994
Status: 🟢 Enrolling Now
Condition: Crohn's Disease (CD)
Phase: PHASE2

Where You Can Participate

This study is available at 20 locations across the country.

Top locations include:
  • • Barnaul, Altai Krai
  • • Ufa, Republic of Bashkortostan
  • • Kazan, Republic of Tatarstan
  • • And 17 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease - Join Clinical Trial NCTNCT07078994

How to Join This Clinical Trial - NCTNCT07078994

Learn how to participate in this PHASE2 trial studying an investigational therapy for Crohn's Disease (CD). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Crohn's Disease (CD). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Crohn's Disease (CD)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07078994 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 20 locations. Find a study site near you:

Clinical Research Site

Barnaul, Altai Krai 656049 - Russian Federation

Status: RECRUITING

Clinical Research Site

Ufa, Republic of Bashkortostan 450005 - Russian Federation

Status: RECRUITING

Clinical Research Site

Kazan, Republic of Tatarstan 420064 - Russian Federation

Status: RECRUITING

Clinical Research Site

Rostov-on-Don, Rostov region 344022 - Russian Federation

Status: RECRUITING

Clinical Research Site

Rostov-on-Don, Rostov region 344022 - Russian Federation

Status: RECRUITING

Clinical Research Site

Chelyabinsk, 454092 - Russian Federation

Status: RECRUITING

Clinical Research Site

Krasnoyarsk, 60037 - Russian Federation

Status: RECRUITING

Clinical Research Site

Krasnoyarsk, 660022 - Russian Federation

Status: RECRUITING

Clinical Research Site

Moscow, 105554 - Russian Federation

Status: RECRUITING

Clinical Research Site

Moscow, 111123 - Russian Federation

Status: RECRUITING

And 10 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Crohn's Disease (CD):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships